GLUE logo
Monte Rosa Therapeutics, Inc.(GLUE)
Last print unknown agoAbout this dataData status
$10.66▲0.92 (9.45%)Stale · unknown old

GLUE Change in Working Capital

$110.67MTTM · USD

Period ending:

GLUE FY Change in Working CapitalUSD
GLUE FY Change in Working Capital2019-12-31: $1.77M2020-12-31: $4.26M2021-12-31: $6.29M2022-12-31: -$2.13M2023-12-31: $72.47M2024-12-31: $91.40M2025-12-31: -$9.19M$91.40M-$9.19M
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

GLUE change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Monte Rosa Therapeutics Inc Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-9,189,000
91,397,000
72,466,000
-2,134,000
6,286,000
4,255,000
1,771,000

Compare change in working capital

All GLUE financial metrics · GLUE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.